Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 20.16 +0.42 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.74 | 52 Week High | $42.49 | |||
| Open | $19.58 | 52 Week Low | $16.64 | |||
| Day High | $20.29 | P/E | N/A | |||
| Day Low | $19.51 | EPS | $-0.42 | |||
| Volume | 664,270 | |||||
